Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0PO7F
|
||||
Former ID |
DIB020403
|
||||
Drug Name |
MRL20
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [527337] | ||
Structure |
Download2D MOL |
||||
Formula |
C28H24F3NO6
|
||||
InChI |
InChI=1S/C28H24F3NO6/c1-16-22(14-19-6-4-5-7-25(19)37-17(2)27(34)35)23-15-21(38-28(29,30)31)12-13-24(23)32(16)26(33)18-8-10-20(36-3)11-9-18/h4-13,15,17H,14H2,1-3H3,(H,34,35)/t17-/m0/s1
|
||||
InChIKey |
BWTOBMCYVACNJZ-KRWDZBQOSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | mRNA of PPAR-gamma | Target Info | Agonist | [527337] | |
PANTHER Pathway | CCKR signaling map ST | ||||
WikiPathways | Wnt Signaling Pathway Netpath | ||||
Nuclear Receptors in Lipid Metabolism and Toxicity | |||||
Differentiation of white and brown adipocyte | |||||
Regulation of Lipid Metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha) | |||||
Transcriptional Regulation of White Adipocyte Differentiation | |||||
Adipogenesis | |||||
SREBP signalling | |||||
Nuclear Receptors | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.